Indian Journal of Animal Research

Indian Journal of Animal Research cover
Volume 60 · Issue 8 · 2026/06/29

Prodigiosin in Neurodegeneration: A Critical Review, Comparative Analysis and Translational Gap Assessment

Ashraf Albrakati
173 Views

Submitted

2026/04/23

First Online

2026/06/29

doi

10.18805/IJAR.BF-2135

Cite article - Ashraf Albrakati. (2026). Prodigiosin in Neurodegeneration: A Critical Review, Comparative Analysis and Translational Gap Assessment. Indian Journal of Animal Research. 60(8): 1357–1367. doi: 10.18805/IJAR.BF-2135

Abstract

Neurodegenerative diseases, including alzheimer’s disease (AD), parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), share interconnected pathogenic mechanisms-oxidative stress, mitochondrial dysfunction, neuroinflammation and progressive neuronal loss-for which available interventions remain largely symptomatic, sustaining interest in pleiotropic natural compounds. This critical narrative review evaluates prodigiosin-a bacterial tripyrrole pigment produced by serratia marcescens-as a candidate neuroprotective compound, situates its evidence against established natural antioxidants (Curcumin, quercetin and resveratrol) and identifies translational gaps through a structured gap analysis. A structured narrative search was conducted across PubMed, Scopus, Web of Science and Google Scholar (2010-2025), combining prodigiosin with neurodegeneration-related descriptors. Given the sparse and heterogeneous evidence base, a critical narrative rather than systematic review framework was applied. Prodigiosin may modulate multiple neuroprotective pathways: (1) Nrf2/HO-1 antioxidant activation (enhanced SOD, CAT, GPx; reduced MDA and nitric oxide); (2) NF-κB suppression (downregulated IL-1β, TNF-α, COX-2, iNOS); (3) apoptosis attenuation via Bcl-2/Bax modulation and caspase-3 reduction and (4) partial restoration of neurotransmitter and neurotrophic (BDNF) indices. However, the evidence derives predominantly from a single research cluster using aluminum chloride models and lacks pharmacokinetic characterization, blood-brain barrier penetration data, independent replication and transgenic model validation.

References

  1. Al Omairi, N.E., Albrakati, A., Alsharif, K.F., Almalki, A.S., Alsanie, W., Elmageed, Z.Y.A. , Zaafar, D., Lokman, M.S., Bauomy, A.A., Belal, S.K., Abdel-Daim, M.M., Moneim, A.E.A., Alyami, H. and Kassab, R.B. (2022). Selenium nanoparticles with prodigiosin rescue hippocampal damage associated with epileptic seizures induced by pentylenetetrazole in rats. Biology (Basel) . 11(3): 354; https://doi.org/10.3390/ biology11030354. Albaqami, J., (2026). Antioxidant activity of cefotaxime with Mg (II) metal ion and novel evaluation of its anticancer capacity against PANC-1 with chemical and spectroscopic characterization. Indian Journal of Animal Research . 60(5): 816-823. doi: 10.18805/IJAR.BF-2074 . Albrakati, A., Alsharif, K.F., Al Omairi, N.E., Alsanie, W.F., Almalki, A.S.A., Elmageed, Z.Y. A., Elshopakey, G.E., Lokman, M.S., Bauomy, A.A., Abdel Moneim, A.E. and Kassab, R.B. (2021). Neuroprotective efficiency of prodigiosins conjugated with selenium nanoparticles in rats exposed to chronic unpredictable mild stress is mediated through antioxidative, anti-inflammatory, anti-apoptotic and neuromodulatory activities. Int. J. Nanomedicine . 16: 8447-8464. Alsharif, K.F., Albrakati, A., Al Omairi, N.E., Almalki, A.S., Alsanie, W., Elmageed, Z.Y.A., Alharthi, F., Althagafi, H.A., Alghamdi, A.A.A., Hassan, I.E., Habotta, O.A., Lokman, M.S., Kassab, R.B. and El-Hennamy, R.E. (2023). Neuroprotective efficacy of the bacterial metabolite, prodigiosin, against aluminium chloride-induced neurochemical alternations associated with alzheimer’s disease murine model: Involvement of Nrf2/HO-1/NF-κB signaling. Environ. Toxicol . 38(2): 266-277. Arivizhivendhan, K.V., Mahesh, M., Boopathy, R., Swarnalatha, S., Regina, M.R. and Sekaran, G. (2018). Antioxidant and antimicrobial activity of bioactive prodigiosin produces from Serratia marcescens using agricultural waste as a substrate. J. Food Sci. Technol . 55(7): 2661-2670. Armstrong, M.J. and Okun, M.S. (2020). Diagnosis and treatment of parkinson disease: A review. Jama . 323(6): 548-560. Ayala, A., Muñoz, M.F. and Argüelles, S. (2014). Lipid peroxidation: production, metabolism and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell Longev. 2014: 360438. Bonora, M., Giorgi, C. and Pinton, P. (2022). Molecular mechanisms and consequences of mitochondrial permeability transition. Nat. Rev. Mol. Cell. Biol . 23(4): 266-285. Caldecott, K.W. (2024). Causes and consequences of DNA single- strand breaks. Trends Biochem. Sci . 49(1): 68-78. Chang, C.C., Wang, Y.H., Chern, C.M., Liou, K.T., Hou, Y.C., Peng, Y.T. and Shen, Y.C. (2011). Prodigiosin inhibits gp91(phox) and iNOS expression to protect mice against the oxidative/ nitrosative brain injury induced by hypoxia-ischemia. Toxicol. Appl. Pharmacol . 257(1): 137-147. Choi, S., Park, N.J., Kim, M., Song, K. and Choi, J. (2023). Comparison of cardiovascular disease risk in women with and without breast cancer: Secondary data analysis with the 2014- 2018 korean national health and nutrition examination survey. BMC Public Health. 23(1): 1158. Darshan, N. and Manonmani, H.K. (2015). Prodigiosin and its potential applications. J. Food Sci. Technol . 52(9): 5393-5407. Heneka, M.T., Kummer, M.P. and Latz, E. (2014). Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol . 14(7): 463-477. Hu, D.X., Withall, D.M., Challis, G.L. and Thomson, R.J. (2016). Structure, chemical synthesis and biosynthesis of prodiginine natural products. Chem. Rev. 116(14): 7818-7853. Islan, G.A., Rodenak-Kladniew, B., Noacco, N., Duran, N. and Castro, G.R. (2022). Prodigiosin: A promising biomolecule with many potential biomedical applications. Bioengineered . 13(6): 14227-14258. Katselou, M.G., Matralis, A.N. and Kourounakis, A.P. (2014). Multi- target drug design approaches for multifactorial diseases: From neurodegenerative to cardiovascular applications. Curr. Med. Chem . 21(24): 2743-2787. Krishna, P.S., Vani, K., Prasad, M.R., Samatha, B., Bindu, N.S., Charya, M.A. and Shetty, P.R. (2013). In silico molecular docking analysis of prodigiosin and cycloprodigiosin as COX-2 inhibitors. Springerplus . 2(1): 172. Long, K., Du, X., Yan, Z. and Xu, J. (2022). Rhoifolin provides neuroprotection against spinal cord injury by attenuation of oxidative stress, inflammation and apoptosis in rats. Indian Journal of Animal Research . 57(1): 82-89. doi: 10.18805/IJAR.BF-1480 . Lu, Y., Liu, D., Jiang, R., Li, Z. and Gao, X. (2024). Prodigiosin: unveiling the crimson wonder-A comprehensive journey from diverse bioactivity to synthesis and yield enhancement. Front. Microbiol . 15: 1412776. Lustoza, R.T.C.M., de Sousa, N.F., Dos Santos, A.M.F., Guimarães, R.D.A., Scotti, M.T. and Scotti, L. (2023). Challenges and discoveries in polypharmacology of neurodegenerative diseases. Curr. Top. Med. Chem . 23(5): 349-370. Mohammed, A.Z., Mubarak, M., Rudayni, H., Aljarba, N., Alkahtani, S., Nasr, F. and Al-Eissa, M. (2025). Lycopene supplement restores the oxidation/antioxidation balance through efficient antioxidant activities in wistar rats with cadmium- induced oxidative stress. Indian Journal of Animal Research . 59(5): 785-790. doi: 10.18805/IJAR.B-5536 . Mohammed, A.E.N., Al-Suwaiegh, S., Algherair, I., Alessa, F. and Alhujaili, W. (2024). Promising roles of Zingiber officinale and its derivatives on promoting health and protecting from disorders. Indian Journal of Animal Research . 58(11): 1949-1955. doi: 10.18805/IJAR.BF-1788 . Nakamura, T., Oh, C.K., Zhang, X. and Lipton, S.A. (2021). Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration. Free. Radic. Biol. Med . 172: 562- 577. Olufunmilayo, E.O., Gerke-Duncan, M.B. and Holsinger, R.M.D. (2023). Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants (Basel ). 12(2): 517. doi: 10.3390/ antiox12020517. Singh, A., Kukreti, R., Saso, L. and Kukreti, S. (2019). Oxidative stress: A key modulator in neurodegenerative diseases. Molecules . 24(8): 1583. doi: 10.3390/molecules24081583. Stankovic, N., Senerovic, L., Ilic-Tomic, T., Vasiljevic, B. and Nikodinovic-Runic, J. (2014). Properties and applications of undecylprodigiosin and other bacterial prodigiosins. Appl. Microbiol. Biotechnol . 98(9): 3841-3858. Van Schependom, J. and D’Haeseleer, M. (2023). Advances in neurodegenerative diseases. J. Clin. Med. 12(5): 1709. doi: 10.3390/jcm12051709. Zhao, R.Z., Jiang, S., Zhang, L. and Yu, Z.B. (2019). Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med . 44(1): 3-15.
EDITORIAL BOARD

Guided by Experienced Academic Leadership

Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.

View Full Board
Yashpal Singh Malik
Chief Editor

Yashpal Singh Malik

Deputy Director General (Agricultural Education)Indian Council of Agricultural Research, Headquarters, New Delhi , India

L.D. Singla
Associate chief editor

L.D. Singla

Professor and HeadAbhilashi University, Chachyot, Himachal Pradesh, India

Vilas G. Atkare
Editor

Vilas G. Atkare

DeanDr. Panjabrao Deshmukh Krishi Vidyapeeth, Akola, Krishi Nagar, Maharashtra, India

S. Maya
Editor

S. Maya

Associate Dean and Professor & HeadKerala Veterinary and Animal Sciences University, Mannuthy, Thrissur, Kerala, India